BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Allam-Ndoul B, Castonguay-Paradis S, Veilleux A. Gut Microbiota and Intestinal Trans-Epithelial Permeability. Int J Mol Sci 2020;21:E6402. [PMID: 32899147 DOI: 10.3390/ijms21176402] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Li X, Li C, Li Y, Liu C, Liang X, Liu T, Liu Z. Sodium nitroprusside protects HFD induced gut dysfunction via activating AMPKα/SIRT1 signaling. BMC Gastroenterol 2021;21:359. [PMID: 34600475 DOI: 10.1186/s12876-021-01934-y] [Reference Citation Analysis]
2 Malesza IJ, Malesza M, Walkowiak J, Mussin N, Walkowiak D, Aringazina R, Bartkowiak-Wieczorek J, Mądry E. High-Fat, Western-Style Diet, Systemic Inflammation, and Gut Microbiota: A Narrative Review. Cells 2021;10:3164. [PMID: 34831387 DOI: 10.3390/cells10113164] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Wei R, Liu X, Wang Y, Dong J, Wu F, Mackenzie GG, Su Z. (-)-Epigallocatechin-3-gallate mitigates cyclophosphamide-induced intestinal injury by modulating the tight junctions, inflammation and dysbiosis in mice. Food Funct 2021;12:11671-85. [PMID: 34730149 DOI: 10.1039/d1fo01848e] [Reference Citation Analysis]
4 Ramos S, Martín MÁ. Impact of diet on gut microbiota. Current Opinion in Food Science 2021;37:83-90. [DOI: 10.1016/j.cofs.2020.09.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
5 Abenavoli L, Scarpellini E, Pellicano R, Fagoonee S, Larussa T, Luzza F. Mediterranean diet and probiotics supplementation to treat non-alcoholic fatty liver disease. Minerva Med 2020;111:526-8. [PMID: 33140925 DOI: 10.23736/S0026-4806.20.07089-5] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Barbara G, Barbaro MR, Fuschi D, Palombo M, Falangone F, Cremon C, Marasco G, Stanghellini V. Corrigendum: Inflammatory and Microbiota-Related Regulation of the Intestinal Epithelial Barrier. Front Nutr 2021;8:790387. [PMID: 34790692 DOI: 10.3389/fnut.2021.790387] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Yang Y, Zhao M, He X, Wu Q, Li DL, Zang WJ. Pyridostigmine Protects Against Diabetic Cardiomyopathy by Regulating Vagal Activity, Gut Microbiota, and Branched-Chain Amino Acid Catabolism in Diabetic Mice. Front Pharmacol 2021;12:647481. [PMID: 34084135 DOI: 10.3389/fphar.2021.647481] [Reference Citation Analysis]
8 Scalise AA, Kakogiannos N, Zanardi F, Iannelli F, Giannotta M. The blood-brain and gut-vascular barriers: from the perspective of claudins. Tissue Barriers 2021;:1926190. [PMID: 34152937 DOI: 10.1080/21688370.2021.1926190] [Reference Citation Analysis]
9 Wagenaar CA, van de Put M, Bisschops M, Walrabenstein W, de Jonge CS, Herrema H, van Schaardenburg D. The Effect of Dietary Interventions on Chronic Inflammatory Diseases in Relation to the Microbiome: A Systematic Review. Nutrients 2021;13:3208. [PMID: 34579085 DOI: 10.3390/nu13093208] [Reference Citation Analysis]
10 Mo X, Sun Y, Liang X, Li L, Hu S, Xu Z, Liu S, Zhang Y, Li X, Liu L. Insoluble yeast β-glucan attenuates high-fat diet-induced obesity by regulating gut microbiota and its metabolites. Carbohydrate Polymers 2022;281:119046. [DOI: 10.1016/j.carbpol.2021.119046] [Reference Citation Analysis]
11 Zhao X, Zhong X, Liu X, Wang X, Gao X. Therapeutic and Improving Function of Lactobacilli in the Prevention and Treatment of Cardiovascular-Related Diseases: A Novel Perspective From Gut Microbiota. Front Nutr 2021;8:693412. [PMID: 34164427 DOI: 10.3389/fnut.2021.693412] [Reference Citation Analysis]
12 Dash S, Syed YA, Khan MR. Understanding the Role of the Gut Microbiome in Brain Development and Its Association With Neurodevelopmental Psychiatric Disorders. Front Cell Dev Biol 2022;10:880544. [DOI: 10.3389/fcell.2022.880544] [Reference Citation Analysis]
13 Philips CA, Augustine P. Gut Barrier and Microbiota in Cirrhosis. Journal of Clinical and Experimental Hepatology 2021. [DOI: 10.1016/j.jceh.2021.08.027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Zhang Y, Wang YY, Luo HY, Liao HW, Zhou KB, Yan B, Yang XF. Interrelationship between gut microbiota and sepsis. Shijie Huaren Xiaohua Zazhi 2022; 30(2): 109-113 [DOI: 10.11569/wcjd.v30.i2.109] [Reference Citation Analysis]
15 Eshghjoo S, Jayaraman A, Sun Y, Alaniz RC. Microbiota-Mediated Immune Regulation in Atherosclerosis. Molecules 2021;26:E179. [PMID: 33401401 DOI: 10.3390/molecules26010179] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
16 Filipovic B, Lukic S, Mijac D, Marjanovic-Haljilji M, Vojnovic M, Bogdanovic J, Glisic T, Filipovic N, Al Kiswani J, Djokovic A, Kapor S, Kapor S, Bukumiric Z, Starcevic A. The New Therapeutic Approaches in the Treatment of Non-Alcoholic Fatty Liver Disease. Int J Mol Sci 2021;22:13219. [PMID: 34948020 DOI: 10.3390/ijms222413219] [Reference Citation Analysis]
17 Chen L, Pu Y, Xu Y, He X, Cao J, Ma Y, Jiang W. Anti-diabetic and anti-obesity: Efficacy evaluation and exploitation of polyphenols in fruits and vegetables. Food Research International 2022;157:111202. [DOI: 10.1016/j.foodres.2022.111202] [Reference Citation Analysis]
18 Mujagic Z, Kasapi M, Jonkers DM, Garcia-Perez I, Vork L, Weerts ZZRM, Serrano-Contreras JI, Zhernakova A, Kurilshikov A, Scotcher J, Holmes E, Wijmenga C, Keszthelyi D, Nicholson JK, Posma JM, Masclee AA. Integrated fecal microbiome-metabolome signatures reflect stress and serotonin metabolism in irritable bowel syndrome. Gut Microbes 2022;14:2063016. [PMID: 35446234 DOI: 10.1080/19490976.2022.2063016] [Reference Citation Analysis]
19 Kapoor D, Khan A, O'Donnell MJ, Kolosov D. Novel mechanisms of epithelial ion transport: insights from the cryptonephridial system of lepidopteran larvae. Curr Opin Insect Sci 2021;47:53-61. [PMID: 33866042 DOI: 10.1016/j.cois.2021.04.001] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Barbara G, Barbaro MR, Fuschi D, Palombo M, Falangone F, Cremon C, Marasco G, Stanghellini V. Inflammatory and Microbiota-Related Regulation of the Intestinal Epithelial Barrier. Front Nutr 2021;8:718356. [PMID: 34589512 DOI: 10.3389/fnut.2021.718356] [Reference Citation Analysis]
21 Zheng Z, Xiao Y, Ma L, Lyu W, Peng H, Wang X, Ren Y, Li J. Low Dose of Sucralose Alter Gut Microbiome in Mice. Front Nutr 2022;9:848392. [DOI: 10.3389/fnut.2022.848392] [Reference Citation Analysis]
22 Zhou A, Yuan Y, Yang M, Huang Y, Li X, Li S, Yang S, Tang B. Crosstalk Between the Gut Microbiota and Epithelial Cells Under Physiological and Infectious Conditions. Front Cell Infect Microbiol 2022;12:832672. [DOI: 10.3389/fcimb.2022.832672] [Reference Citation Analysis]
23 Nickel L, Sünderhauf A, Rawish E, Stölting I, Derer S, Thorns C, Matschl U, Othman A, Sina C, Raasch W. The AT1 Receptor Blocker Telmisartan Reduces Intestinal Mucus Thickness in Obese Mice. Front Pharmacol 2022;13:815353. [DOI: 10.3389/fphar.2022.815353] [Reference Citation Analysis]
24 Qin X, Zou H, Niu C. The STING pathway: An uncharacterized angle beneath the gut-retina axis. Exp Eye Res 2022;:108970. [PMID: 35114214 DOI: 10.1016/j.exer.2022.108970] [Reference Citation Analysis]
25 Zeng RZ, Lv XD, Liu GF, Gu GL, Li SQ, Chen L, Fan JH, Liang ZL, Wang HQ, Lu F, Zhan LL, Lv XP. The Correlation Between MYO9B Gene Polymorphism and Inflammatory Bowel Disease in the Guangxi Zhuang Population. Int J Gen Med 2021;14:9163-72. [PMID: 34880655 DOI: 10.2147/IJGM.S338142] [Reference Citation Analysis]
26 Yuan Y, Lu L, Bo N, Chaoyue Y, Haiyang Y. Allicin Ameliorates Intestinal Barrier Damage via Microbiota-Regulated Short-Chain Fatty Acids-TLR4/MyD88/NF-κB Cascade Response in Acrylamide-Induced Rats. J Agric Food Chem 2021;69:12837-52. [PMID: 34694121 DOI: 10.1021/acs.jafc.1c05014] [Reference Citation Analysis]